Table 1. Patient clinical characteristics and BRAF genotype.
Patient no. | Age (years) | Gender | Smoking status | Procedure | Predominant histological subtype | Other components | BRAF mutation |
---|---|---|---|---|---|---|---|
1 | 51 | F | Ex-smoker 15 pk yrs | Lung FNA | Non-small cell carcinoma, NOS | V600E | |
2 | 57 | F | Ex-smoker pk yrs not known | Resection | Adenocarcinoma—lepidic | Papillary | G469V |
3 | 70 | F | Ex-smoker 10 pk yrs | Resection | Adenocarcinoma—micropapillary | Lepidic | V600E |
4 | 70 | M | Ex-smoker 90 pk yrs | Lung core biopsy | Adenocarcinoma—acinar | Papillary and lepidic | K601N |
5 | 73 | F | Ex-smoker 40 pk yrs | Bronchial washing | Adenocarcinoma | V600E | |
6 | 74 | M | Ex-smoker 40 pk yrs | Bronchial biopsy | Adenocarcinoma | L597Q | |
7 | 76 | M | Ex-smoker 3 pk yrs | Resection | Adenocarcinoma—micropapillary | Acinar | V600E |
F, female; M, male; NOS, not otherwise specified.